Andrew X. Zhu

Also affiliated with Drexel University, Icahn School of Medicine at Mount Sinai

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 17 papers. Top paper: “Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma”.

Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma

New England Journal of Medicine(2020)10.1056/nejmoa1915745

N/A

1.3DataRank · unranked

7029 citations

Shukui Qin, Masafumi Ikeda, Peter R. Galle, Michel Ducreux, Tae-You Kim +19 more

Regorafenib combined with PD1 blockade increases CD8 T-cell infiltration by inducing CXCL10 expression in hepatocellular carcinoma

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-001435

N/A

0.754DataRank · unranked

151 citations

Aya Matsui, Hiroto Kikuchi, Sebastian Klein, Émilie Mamessier, Ivy X. Chen +21 more

A model for decoding resistance in precision oncology: acquired resistance to FGFR inhibitors in cholangiocarcinoma

Annals of Oncology(2024)10.1016/j.annonc.2024.12.011

N/A

0.538DataRank · unranked

35 citations

Daniel DiToro, Francesco Facchinetti, E Martin, P. Peng, Islam Baiev +50 more

Obesity/Type 2 Diabetes-Associated Liver Tumors Are Sensitive to Cyclin D1 Deficiency

Cancer Research(2020)10.1158/0008-5472.can-20-0106

N/A

0.464DataRank · unranked

21 citations

Jiaxin Liang, Kfir Sharabi, Maximilian Hatting, Elizabeth A. Perry, Clint D.J. Tavares +7 more

Characterization of cell states in biliary tract cancers identifies mechanisms of therapeutic resistance in a phase II trial of DKN-01/nivolumab

medRxiv(2024)10.1101/2024.10.08.24315092

N/A

0.208DataRank · unranked

3 citations

Milan Parikh, Leon Pappas, Moshe Sade-Feldman, Anupriya S. Kulkarni, Lynn Bi +19 more

Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH -Mutant Molecular Profiles

UNC Libraries(2020)10.17615/7ms0-1a34

N/A

0DataRank · unranked

0 citations

Umadevi Veluvolu, Mario Berríos, David E. Kleiner, Donghui Tan, Johanna Gardner +95 more

Placental growth factor promotes tumour desmoplasia and treatment resistance in intrahepatic cholangiocarcinoma

Gut(2021)10.1136/gutjnl-2020-322493

N/A

0DataRank · unranked

81 citations

Koetsu Inoue, Sebastian Klein, Stefan Halvorsen, Jiang Chen, Aya Matsui +28 more

The clinical landscape of cell-free DNA alterations in 1671 patients with advanced biliary tract cancer

Annals of Oncology(2022)10.1016/j.annonc.2022.09.150

N/A

0DataRank · unranked

143 citations

Francesco Facchinetti, Daniel DiToro, Islam Baiev, Umair Majeed, Sylvia A. Reyes +24 more

EGFR Inhibition Potentiates FGFR Inhibitor Therapy and Overcomes Resistance in FGFR2 Fusion–Positive Cholangiocarcinoma

Cancer Discovery(2022)10.1158/2159-8290.cd-21-1168

N/A

0DataRank · unranked

99 citations

Yuanli Zhen, Lei Shi, Phuong Vu, Patricia Greninger, Ramzi Adil +18 more

Molecular profiling and treatment pattern differences between intrahepatic and extrahepatic cholangiocarcinoma

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad046

N/A

0DataRank · unranked

28 citations

Leontios Pappas, Islam Baiev, Jordan R. Maurer, Andrea Grace Bocobo, Karen Zhang +25 more

Resection of NAFLD/NASH-related Hepatocellular Carcinoma (HCC): Clinical Features and Outcomes Compared with HCC Due to Other Etiologies

The Oncologist(2023)10.1093/oncolo/oyac251

N/A

0DataRank · unranked

22 citations

Stephanie Reyes, Matthew Chase, Aparna Govindan, Lei Zhao, Jay Luther +26 more

Bayesian Calibration of Computational Knee Models to Estimate Subject-Specific Ligament Properties, Tibiofemoral Kinematics, and Anterior Cruciate Ligament Force With Uncertainty Quantification

Journal of Biomechanical Engineering(2023)10.1115/1.4056968

N/A

0DataRank · unranked

8 citations

Hamidreza Jahandar, Andrew X. Zhu, Erin E. Berube, Joseph E. Manzi, Andrew D. Pearle +5 more

NRG/RTOG 1112: Randomized phase III study of sorafenib vs. stereotactic body radiation therapy (SBRT) followed by sorafenib in hepatocellular carcinoma (HCC).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.489

N/A

0DataRank · unranked

60 citations

Kathryn Winter, Jennifer J. Knox, Andrew X. Zhu, Sunil Krishnan, Chandan Guha +15 more

Data from Exploratory Analysis of Early Toxicity of Sunitinib in Advanced Hepatocellular Carcinoma Patients: Kinetics and Potential Biomarker Value

(2023)10.1158/1078-0432.c.6518151

N/A

0DataRank · unranked

0 citations

Dan G. Duda, Marek Ancukiewicz, Emmanuelle di Tomaso, Jeffrey W. Clark, Rebecca A. Miksad +4 more

Trial Design and Endpoints in Hepatocellular Carcinoma: AASLD Consensus Conference

Hepatology(2020)10.1002/hep.31327

N/A

0DataRank · unranked

414 citations

Augusto Villanueva, Jorge A. Marrero, Myron E. Schwartz, Tim Meyer, Peter R. Galle +9 more

Baseline‐to‐loaded changes in regional tibial cartilage thickness, T1ρ and T2: Utilization of an MRI compatible loading device

Journal of Orthopaedic Research®(2024)10.1002/jor.25956

N/A

0DataRank · unranked

5 citations

Ashley Pekmezian, Arden Wach, Andrew X. Zhu, Sonia Bansal, Ryan Breighner +5 more

Serial ctDNA Monitoring to Predict Response to Systemic Therapy in Metastatic Gastrointestinal Cancers

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3467

N/A

0DataRank · unranked

143 citations

Amikasra Mojtahed, Jaime L. Schneider, Katie Kanter, Emily E. Van Seventer, Isobel J. Fetter +25 more